2 Result(s)
within
R Boidot
Biomedicine
Cancer Research
-
Article
Open AccessTumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours
Hypoxia can activate autophagy, a self-digest adaptive process that maintains cell turnover. Mammalian target of rapamycin (mTOR) inhibitors are used to treat cancer but also stimulate autophagy.
-
Article
Open AccessGene expression profile and response to trastuzumab–docetaxel-based treatment in breast carcinoma
Resistance to trastuzumab is often observed in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer and has been shown to involve multiple potential mechanisms. We examined the abi...
